ClinVar Miner

Submissions for variant NM_004380.3(CREBBP):c.2111del (p.Pro704fs)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Clinical Genomics Laboratory, Washington University in St. Louis RCV004555938 SCV005045010 likely pathogenic Rubinstein-Taybi syndrome due to CREBBP mutations 2024-02-29 criteria provided, single submitter clinical testing The CREBBP c.2111del (p.Pro704Glnfs*9) variant, to our knowledge, has not been reported in the medical literature and is absent from the general population (gnomAD v.2.1.1), indicating it is not a common variant. This variant causes a frameshift by deleting a single nucleotide, leading to a premature termination codon, which is predicted to lead to nonsense mediated decay. Additionally, other variants that introduce a premature termination codon in this region have been described in affected individuals and are considered pathogenic (Bentivegna A et al., PMID: 17052327; Schorry EK et al., PMID: 18792986). Based on available information and the ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), this variant is classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.